4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-21-001848
Options or other derivatives
- PRESIDENT AND CEO acquired 1,702,396 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Aggarwal Sumit PRESIDENT AND CEO | 2021-04-01 | Grant or award · Restricted Stock Units | +223,304 | 223,304 | D | ||
| Aggarwal Sumit PRESIDENT AND CEO | 2021-04-01 | Grant or award · Restricted Stock Units | +55,854 | 279,158 | D | ||
| Aggarwal Sumit PRESIDENT AND CEO | 2021-04-01 | Grant or award · Stock Options (Right to Buy) | +1,423,238 | 1,423,238 | D | ||
Loading xslF345X03/form4-04022021_050420.xml…